about
Mathematical model identifies blood biomarker-based early cancer detection strategies and limitationsTargeting the CCL2-CCR2 signaling axis in cancer metastasisTargeting dormant micrometastases: rationale, evidence to date and clinical implicationsCancer Metastases: Early Dissemination and Late RecurrencesThe cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?Chemoquiescence for ideal cancer treatment and prevention: where are we now?Tumor cell migration in complex microenvironmentsInitial steps of metastasis: cell invasion and endothelial transmigrationThe cancer stem cell niche--there goes the neighborhood?Transcriptional changes induced by the tumor dormancy-associated microRNA-190Dormancy of cancer cells with suppression of AKT activity contributes to survival in chronic hypoxia.Global dormancy of metastases due to systemic inhibition of angiogenesisIn vivo evolution of tumor-derived endothelial cells.The pre-metastatic niche: finding common ground.Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib.A cellular automaton model for tumor dormancy: emergence of a proliferative switch.Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype.Prospective identification of glioblastoma cells generating dormant tumors.Biological stoichiometry in tumor micro-environments.Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer.Autophagy: cancer's friend or foe?Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in miceKnockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC).Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapyHighly sensitive detection of cancer cells using femtosecond dual-wavelength near-IR two-photon imaging.Immune microenvironment in tumor progression: characteristics and challenges for therapyHes1: a key role in stemness, metastasis and multidrug resistance.Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells.Repopulation of ovarian cancer cells after chemotherapyTumour dormancy and clinical implications in breast cancer.Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci.Quo vadis radiotherapy? Technological advances and the rising problems in cancer managementBreast cancer as a systemic disease: a view of metastasisComparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladder.Primary and metastatic tumor dormancy as a result of population heterogeneity.The role of hematopoietic stem cell niche in prostate cancer bone metastasis.Expression and epigenetic regulation of angiogenesis-related factors during dormancy and recurrent growth of ovarian carcinomaTissue factor expression provokes escape from tumor dormancy and leads to genomic alterations.Notch regulation of tumor angiogenesis.
P2860
Q24614865-1AFCAA4A-0E00-453F-BF85-0D7911AC85D3Q26765184-2E8E66B6-364A-470A-89B2-8B1B86340FA9Q26765205-7D8F2BD9-9ADE-43AA-9854-6C91A22A2BB5Q26774164-AEA638A1-5F8C-47B3-8C29-812058EF7BF1Q26824147-6D59516A-F9B5-4B41-9E25-9EA3FE4A8166Q27026391-ECF80311-BF37-405D-AB83-39847676AB5CQ27027489-9B35E6EE-C767-4ED9-8B11-1C5C36FD5089Q28238397-78F33FD6-C679-4AC0-A54D-420486644257Q28244178-FF98E3A6-F423-4E3B-A60B-427A8B733AA1Q28383492-06D85B3C-EF6B-4B75-9DFF-2BE742FAF0E6Q30436995-14D7F5FC-B4CA-4C8F-9B86-0051CDDB1466Q31148727-E5BDBC9B-F2C4-4E89-A5EB-019E0967B6D0Q34279817-C5571A66-BA4B-4FAD-9066-9F7D3780884BQ34342357-C5047FA1-3745-4EA6-8772-F3053F059564Q34348270-F17CF07B-C0A8-4B12-BF10-F513B3851748Q34351959-D1392BFA-ECF9-43C5-92C9-53EF9B093C94Q34406041-06B0A736-FF31-490B-859F-ED57E69D9C49Q34412360-F01D0063-672D-4F29-908E-D685D66B32E2Q34562050-CD15AC8C-10F7-48BA-B420-DAE739413288Q34807804-E48DBE9E-2663-4AB6-B38B-7566271716B8Q35146596-4609C4CC-7383-42A3-B428-4431D30D73F6Q35640579-A08A9C27-7D19-4761-B449-C10C65448323Q35760920-5837F575-4EA1-43A4-BFC4-320E02E52790Q35917703-7AB2F0C5-879D-42E6-9401-37616E0BC56FQ36029691-6E2A0704-EB23-4CB2-8E9F-BAF3D1BF1453Q36091467-2206AC8B-BE2B-41F5-8059-845C66F26357Q36178400-D2BCBC4B-87E2-45E5-8E12-DDD27725052EQ36213706-759D2DC3-9E80-44CF-8685-4BD6A9742C44Q36454459-11B32EF2-5824-4999-94F7-8661BE1BA8EFQ36725453-59115C90-C3E3-423A-AC26-61E0B7566890Q36863179-DBA59C1E-92B3-4DDB-B4A0-AE8848701226Q36906789-D3B78B94-AD9F-4F79-9E78-EC36A085D4E7Q36933276-C08CB002-B790-4520-A619-F5DE54EADDE2Q37011741-44BFDD7C-F188-461A-A49C-1353BD68064CQ37152820-6B661B67-2778-4814-9DD9-1EE2F24D0586Q37196014-CE93BEE8-B176-444B-BD21-54EF540104DDQ37337502-1DB7EA23-0987-45A4-AC84-76D598547A42Q37600920-B48BB4A9-3C03-472B-81FE-C3E72E68E52EQ37628002-6B6546ED-FD91-49A4-9BFE-85CA9E2B96B5Q37861206-B61F6344-23A8-46C0-BEBC-5DDDAD54923B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms underlying tumor dormancy.
@en
Molecular mechanisms underlying tumor dormancy.
@nl
type
label
Molecular mechanisms underlying tumor dormancy.
@en
Molecular mechanisms underlying tumor dormancy.
@nl
prefLabel
Molecular mechanisms underlying tumor dormancy.
@en
Molecular mechanisms underlying tumor dormancy.
@nl
P1433
P1476
Molecular mechanisms underlying tumor dormancy.
@en
P2093
Nava Almog
P304
P356
10.1016/J.CANLET.2010.03.004
P407
P577
2010-04-02T00:00:00Z